These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Membrane glucocorticoid receptors (mGCR) are expressed in normal human peripheral blood mononuclear cells and up-regulated after in vitro stimulation and in patients with rheumatoid arthritis. Bartholome B; Spies CM; Gaber T; Schuchmann S; Berki T; Kunkel D; Bienert M; Radbruch A; Burmester GR; Lauster R; Scheffold A; Buttgereit F FASEB J; 2004 Jan; 18(1):70-80. PubMed ID: 14718388 [TBL] [Abstract][Full Text] [Related]
3. Membrane glucocorticoid receptors are down regulated by glucocorticoids in patients with systemic lupus erythematosus and use a caveolin-1-independent expression pathway. Spies CM; Schaumann DH; Berki T; Mayer K; Jakstadt M; Huscher D; Wunder C; Burmester GR; Radbruch A; Lauster R; Scheffold A; Buttgereit F Ann Rheum Dis; 2006 Sep; 65(9):1139-46. PubMed ID: 16449313 [TBL] [Abstract][Full Text] [Related]
4. Comparison of the Bath Ankylosing Spondylitis Disease Activity Index and a modified version of the index in assessing disease activity in patients with ankylosing spondylitis without peripheral manifestations. Song IH; Rudwaleit M; Listing J; Sieper J Ann Rheum Dis; 2009 Nov; 68(11):1701-7. PubMed ID: 19029168 [TBL] [Abstract][Full Text] [Related]
5. Cytokine production from peripheral blood mononuclear cells in patients with ankylosing spondylitis and their first-degree relatives. Chou CT; Huo AP; Chang HN; Tsai CY; Chen WS; Wang HP Arch Med Res; 2007 Feb; 38(2):190-5. PubMed ID: 17227728 [TBL] [Abstract][Full Text] [Related]
6. Increased nuclear factor-kappaB activation in peripheral blood monocytes of patients with rheumatoid arthritis is mediated primarily by tumor necrosis factor-alpha. Dichamp I; Bourgeois A; Dirand C; Herbein G; Wendling D J Rheumatol; 2007 Oct; 34(10):1976-83. PubMed ID: 17896809 [TBL] [Abstract][Full Text] [Related]
7. Development of an ASAS-endorsed disease activity score (ASDAS) in patients with ankylosing spondylitis. Lukas C; Landewé R; Sieper J; Dougados M; Davis J; Braun J; van der Linden S; van der Heijde D; Ann Rheum Dis; 2009 Jan; 68(1):18-24. PubMed ID: 18625618 [TBL] [Abstract][Full Text] [Related]
8. Soluble triggering receptor expressed on myeloid cell-1 (sTREM-1): a new mediator involved in early ankylosing spondylitis. Chen CH; Liao HT; Chen HA; Liang TH; Wang CT; Chou CT J Rheumatol; 2008 Sep; 35(9):1846-8. PubMed ID: 18634145 [TBL] [Abstract][Full Text] [Related]
9. Impaired expression of IgA Fc receptors (CD89) by blood phagocytic cells in ankylosing spondylitis. Montenegro V; Chiamolera M; Launay P; Gonçalves CR; Monteiro RC J Rheumatol; 2000 Feb; 27(2):411-7. PubMed ID: 10685807 [TBL] [Abstract][Full Text] [Related]
10. Serum leptin levels correlate with interleukin-6 levels and disease activity in patients with ankylosing spondylitis. Park MC; Lee SW; Choi ST; Park YB; Lee SK Scand J Rheumatol; 2007; 36(2):101-6. PubMed ID: 17476615 [TBL] [Abstract][Full Text] [Related]
12. Adipose tissue, serum adipokines, and ghrelin in patients with ankylosing spondylitis. Toussirot E; Streit G; Nguyen NU; Dumoulin G; Le Huédé G; Saas P; Wendling D Metabolism; 2007 Oct; 56(10):1383-9. PubMed ID: 17884449 [TBL] [Abstract][Full Text] [Related]
13. [Beta-2-microglobulin and ankylosing spondylitis]. Mateicka F; Cebecauer L; Bosák V; Bosmanský K; Ondrasík M Cas Lek Cesk; 1990 Apr; 129(15):457-61. PubMed ID: 2189571 [TBL] [Abstract][Full Text] [Related]
14. Supplementation of omega-3 fatty acids in patients with ankylosing spondylitis. Sundström B; Stålnacke K; Hagfors L; Johansson G Scand J Rheumatol; 2006; 35(5):359-62. PubMed ID: 17062435 [TBL] [Abstract][Full Text] [Related]
15. [Clinical study of etanercept for treating ankylosing spondylitis]. Liang LQ; Zhan ZP; Ye YJ; Fu D; Xu HS; Yang XY Nan Fang Yi Ke Da Xue Xue Bao; 2008 Aug; 28(8):1349-51. PubMed ID: 18753057 [TBL] [Abstract][Full Text] [Related]
16. Glucocorticoid dose dependent downregulation of glucocorticoid receptors in patients with rheumatic diseases. Sanden S; Tripmacher R; Weltrich R; Rohde W; Hiepe F; Burmester GR; Buttgereit F J Rheumatol; 2000 May; 27(5):1265-70. PubMed ID: 10813299 [TBL] [Abstract][Full Text] [Related]
17. Changes of clinical response and bone biochemical markers in patients with ankylosing spondylitis taking etanercept. Woo JH; Lee HJ; Sung IH; Kim TH J Rheumatol; 2007 Aug; 34(8):1753-9. PubMed ID: 17610317 [TBL] [Abstract][Full Text] [Related]
18. Tumor necrosis factor-alpha blockade leads to decreased peripheral T cell reactivity and increased dendritic cell number in peripheral blood of patients with ankylosing spondylitis. Pang L; Wang L; Suo T; Hao H; Fang X; Jia J; Huang F; Tang J J Rheumatol; 2008 Nov; 35(11):2220-8. PubMed ID: 19004053 [TBL] [Abstract][Full Text] [Related]
19. Osteopontin might be involved in bone remodelling rather than in inflammation in ankylosing spondylitis. Choi ST; Kim JH; Kang EJ; Lee SW; Park MC; Park YB; Lee SK Rheumatology (Oxford); 2008 Dec; 47(12):1775-9. PubMed ID: 18854347 [TBL] [Abstract][Full Text] [Related]
20. Cell surface and relative mRNA expression of heat shock protein 70 in human synovial cells. Sedlackova L; Nguyen TT; Zlacka D; Sosna A; Hromadnikova I Autoimmunity; 2009 Jan; 42(1):17-24. PubMed ID: 18608178 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]